|
 |
Breast Cancer > Antibody
The following information is about Antibody.
Antibody Defined
Protein in the blood that defends against invading foreign agents, such as bacteria; invading agents contain certain chemical substances called antigens - each antibody works against a specific antigen.
This definition is in context to Breast Cancer. See more contextual defintions for Antibody.
Immunomedics Announces Fiscal 2008 Results
Published August 28, 2008, 1:00 pm, GlobeNewswire via Yahoo! Finance
MORRIS PLAINS, N.J., Aug. 28, 2008 -- Immunomedics, Inc. , a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported revenues of $1.0 million and a net loss of $6.9 million, or $0.09 per share, for the fourth quarter of fiscal year 2008, which ended June 30, 2008.
Medical Breakthrough Helping S.A. Cancer Patients
Published August 28, 2008, 11:04 am, WOAI San Antonio
Patients from as far as Laredo and Eagle Pass are coming to San Antonio to receive the new drug.
ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer
Published August 28, 2008, 9:06 am, PR Newswire via Yahoo! Finance
-
ThromboGenics Announces Half Year Results 2008
Published August 28, 2008, 9:04 am, PR Newswire via Yahoo! Finance
ThromboGenics NV , a biotechnology company focused on innovative treatments for eye disease, vascular disease and cancer, is today issuing a business update and its financial results for the six month period ending June 30, 2008.
ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer
Published August 28, 2008, 9:04 am, PR Newswire via Yahoo! Finance
ThromboGenics NV , a biotechnology company focused on novel therapies for eye disease, vascular disease and cancer, announces today that Patrik De Haes, MD, currently Chief Operating Officer, has been appointed to succeed Professor Desire Collen as the Company's new Chief Executive Officer on September 1, 2008.
ImClone: BMS offer for company seen reaching USD 67-70
Published August 28, 2008, 5:22 am, Financial Times
This article is provided to FT.com readers by dealReporter —a news service focused on providing insightful intelligence on event driven situations to investors.
Mouse Study Uncovers Early Trigger For Type-1 Diabetes
Published August 28, 2008, 5:13 am, Medical News Today
Scientists at the Stanford University School of Medicine are shedding light on how type-1 diabetes begins. Doctors have known the disease is caused by an autoimmune attack on the pancreas, but the exact trigger of the attack has been unclear.
Roche's xCELLigence System Offers Dynamic and Label-free Assessing of Kinase Activity in Living Cells
Published August 28, 2008, 5:00 am, Business Wire via Yahoo! Finance
PENZBERG, Germany----The central role of receptor tyrosine kinases in cellular processes, especially in cancer, has made them an important target for several antibody- and small molecule-based inhibitors specific for various RTKs for the treatment of different tumour entities.
Morphotek opens clinical sites in EU for phase II pancreatic cancer drug trial
Published August 27, 2008, 9:43 pm, PharmaBiz
Morphotek, Inc, a subsidiary of Eisai Corporation of North America, announced that it has opened clinical sites in the European Union (EU) as part of the company's MORAb-009 phase-II study.
Genmab Announces 2008 First Half Year Results
Published August 27, 2008, 9:41 am, PR Newswire via Yahoo! Finance
Genmab A/S announced today results for the six month period ended June 30, 2008. During this period, Genmab reported the following results:
Are you looking for additional Breast Cancer > Antibody news? Try our new "Antibody News Focus" area.
Off-site Antibody Links, User Submitted
The following links have been collected through user bookmark submission in the Antibody category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Thu Aug 28
Tue Aug 26
Mon Aug 25
- Melbourne doctors move closer to wonder cures
- Antibody Engineering Cuts Collateral Damage of Cancer Drugs: Killing cancer cells, while leaving normal tissue unscathed, is almost impossible. Nanotechnology may do the trick, but big pharmaceutical companies are far from embracing that strategy. In the meantime, highly-enginee red biological molecules will fill the void.
Fri Aug 22
- CSF B--lymphocyte chemoattractan t (CXCL13) in the ...[J Neurol. 2008] - PubMed Result: Norway, 2008 (abstract only). A chemical in the spinal fluid, B-lymphocyte attracting chemokine (CXCL13) may be diagnostic for neurological Lyme disease, as shown in this study of 59 consecutive patients referred for possible neuroborrelios is.
Thu Aug 21
Mon Aug 18
- Remembrance of viruses past : Nature News
- www.bioinf.org .uk : Dr. Andrew C.R. Martin's Group at UCL: This page provides an automatically updated summary of all antibody structures in the Protein Databank
- TheStar.com | News & Features | Antibodies from 1918 flu still work well, study says
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Antibody. If you would like to find related tags we recommend Tag Patterns > Antibody
Off-site Antibody Research Links
If you still need additional information on Antibody then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Breast Cancer Topics
Everything you need to know about Breast Cancer
Breast Cancer
If you know the Breast Cancer Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Breast-Cancer.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
Best Viewed With
License
This work is licensed under Creative Commons.